F Rabbani

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance
    F Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:94-100. 2001
  2. doi request reprint Pure primary prostatic osteosarcoma arising in a non-irradiated prostate
    Farhang Rabbani
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Urol Int 83:236-8. 2009
  3. doi request reprint Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:605-10. 2009
  4. doi request reprint Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy
    Farhang Rabbani
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Sex Med 7:166-81. 2010
  5. doi request reprint Impact of ethnicity on surgical margins at radical prostatectomy
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:904-8. 2009
  6. doi request reprint Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation
    Farhang Rabbani
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:1252-7. 2009
  7. doi request reprint Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur Urol 57:371-86. 2010
  8. ncbi request reprint Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology
    Farhang Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1057-61. 2004
  9. ncbi request reprint Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors
    Farhang Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:2370-5. 2002
  10. ncbi request reprint Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse
    F Rabbani
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:2020-5. 2001

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance
    F Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:94-100. 2001
    ....
  2. doi request reprint Pure primary prostatic osteosarcoma arising in a non-irradiated prostate
    Farhang Rabbani
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Urol Int 83:236-8. 2009
    ..The tumor was composed of two nodules measuring 7.5 and 4.5 cm involving the prostate, both seminal vesicles, the bladder, rectum, and perirectal fibroadipose tissue. The final diagnosis was osteogenic sarcoma of the prostate...
  3. doi request reprint Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:605-10. 2009
    ....
  4. doi request reprint Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy
    Farhang Rabbani
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Sex Med 7:166-81. 2010
    ....
  5. doi request reprint Impact of ethnicity on surgical margins at radical prostatectomy
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:904-8. 2009
    ....
  6. doi request reprint Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation
    Farhang Rabbani
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:1252-7. 2009
    ....
  7. doi request reprint Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy
    Farhang Rabbani
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur Urol 57:371-86. 2010
    ..The lack of standardized reporting of the complications of radical prostatectomy in the literature has made it difficult to compare incidences across institutions and across different surgical approaches...
  8. ncbi request reprint Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology
    Farhang Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1057-61. 2004
    ..We determined the prognostic significance of renal vein or inferior vena caval (IVC) extension in patients with nonmetastatic renal cell carcinoma (RCC) or oncocytoma undergoing surgery...
  9. ncbi request reprint Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors
    Farhang Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:2370-5. 2002
    ....
  10. ncbi request reprint Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse
    F Rabbani
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:2020-5. 2001
    ..In contrast, patients with elevated markers before retroperitoneal lymphadenectomy have a high rate of relapse and should be considered for primary chemotherapy...
  11. doi request reprint Preperitoneal repair of inguinal hernia at open radical prostatectomy
    I L Savetsky
    Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Hernia 13:517-22. 2009
    ..Dissection of the preperitoneal space at RP provides an ideal opportunity for the repair of inguinal hernia. We describe our efforts with patients undergoing RP and IHR to determine whether this approach is safe...
  12. ncbi request reprint Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis
    Kamal S Pohar
    Department or Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 170:1155-8. 2003
    ..We determined the pathological findings and clinical outcome of patients with pure embryonal carcinoma (EC) of the testis managed by primary retroperitoneal lymph node dissection...
  13. ncbi request reprint Cancer control with radical prostatectomy alone in 1,000 consecutive patients
    Gerald W Hull
    Department of Urology, Medical University of South Carolina, Charleston, USA
    J Urol 167:528-34. 2002
    ..We analyzed the long-term progression-free probability after radical retropubic prostatectomy in a consecutive series of patients with localized prostate cancer...
  14. ncbi request reprint Editorial comment on: prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy
    Farhang Rabbani
    Eur Urol 52:723-4. 2007
  15. ncbi request reprint Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 5:157-64. 2006
    ..To report PSA relapse-free survival and toxicity outcomes of prostate cancer patients who have undergone three-dimensional computer-optimized high-dose-rate (HDR) brachytherapy with external beam radiotherapy as definitive treatment...
  16. pmc The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer
    Timothy A Masterson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 175:1320-4; discussion 1324-5. 2006
    ....
  17. ncbi request reprint A population-based study of renal cell carcinoma and prostate cancer in the same patients
    Daniel A Barocas
    Department of Urology, James Buchanan Brady Foundation, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY 10021, USA
    BJU Int 97:33-6. 2006
    ..To investigate the incidence of prostate cancer in men with renal cell carcinoma (RCC) and the incidence of RCC in men with prostate cancer...
  18. ncbi request reprint Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival
    Lee Richstone
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:615-20. 2004
    ..We determined the frequency of tumor multifocality in patients with renal cortical tumors, characterized clinical and pathological features associated with multifocality and evaluated its effect on patient survival...
  19. ncbi request reprint Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population
    Deborah Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 65:1118-25. 2005
    ..To describe the population-based patterns of care among patients with muscle-invasive bladder cancer...
  20. ncbi request reprint Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder
    Guido Dalbagni
    Department of Urology, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 20:3193-8. 2002
    ..The aim of this phase I study was to determine the safety and toxicity profile of gemcitabine administered as an intravesical agent in patients with transitional-cell carcinoma (TCC) of the bladder...
  21. ncbi request reprint Adherence to surveillance among patients with superficial bladder cancer
    Deborah Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 95:588-97. 2003
    ..We examined the degree to which bladder cancer patients undergo the recommended surveillance procedures and identified patient and primary care provider characteristics associated with nonadherence to these recommendations...
  22. ncbi request reprint Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors
    Joel Sheinfeld
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 170:1159-62. 2003
    ..We determined the incidence and clinical outcome of patients with clinical stages I and IIA nonseminomatous germ cell tumors (NSGCT), and teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection (RPLND)...
  23. ncbi request reprint A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 170:1798-803. 2003
    ..We developed a preoperative nomogram for prediction of lymph node metastases in patients with clinically localized prostate cancer...
  24. ncbi request reprint Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma
    Farhang Rabbani
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 62:1092-6. 2003
    ..To determine the pathologic findings and clinical outcome of patients with pure teratoma of the testis who underwent primary or postchemotherapy retroperitoneal lymphadenectomy (RPLND)...
  25. ncbi request reprint Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods
    Ming Lan Lu
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 8:171-9. 2002
    ..015), and it appears to be a significant prognostic factor associated with patient survival...
  26. ncbi request reprint Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 11021, USA
    J Clin Oncol 20:2025-30. 2002
    ..The purpose of this study was to determine whether the extent of palpable cancer within the prostate predicts outcome after radical prostatectomy...
  27. ncbi request reprint Evaluation of genitofemoral nerve donor site morbidity after radical prostatectomy
    Matthew S Kilgo
    Division of Plastic and Reconstructive Surgery and Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Plast Surg 55:57-61; discussion 61-2. 2005
    ..The sural nerve is commonly used as a donor site for cavernous nerve grafting. However, the genitofemoral nerve is accessible and easily dissected and may represent an improved donor site for this procedure...
  28. ncbi request reprint Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%
    Karim Touijer
    Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 178:120-4. 2007
    ..We also determined the feasibility of laparoscopic standard pelvic lymph node dissection...
  29. ncbi request reprint Is year of radical prostatectomy a predictor of outcome in prostate cancer?
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:692-6. 2004
    ..We examined whether the year in which radical prostatectomy (RP) was performed is a predictor of treatment outcome after controlling for standard prognostic factors...
  30. pmc Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    Zohar A Dotan
    Department of Quantitative Health Sciences, The Cleveland Clinic Foundation, 9500 Euclid Avenue Wb 4, Cleveland, OH 44195, USA
    J Clin Oncol 23:1962-8. 2005
    ..We studied patient characteristics to build a predictive model for a positive scan...